• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Myomectomy Companies

    ID: MRFR/MED/3713-HCR
    110 Pages
    Kinjoll Dey
    September 2025

    In the field of gynecology, Myomectomy companies specialize in developing advanced surgical techniques and tools for the removal of uterine fibroids. These companies play a crucial role in providing safe and effective solutions for women's reproductive health.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Myomectomy Market

    Myomectomy Market


    Latest Myomectomy Companies Updates


    October 2021: Hologic Inc. acquired Bolder Surgical, gaining advanced vessel sealing devices and strengthening their surgical portfolio.


    August 2020: Hologic Inc. acquired Acessa Health Inc., bolstering their fibroid treatment options with minimally invasive solutions.


    November 2022: Olympus launched the moresolution Power Morcellator, catering to surgeons dealing with large, calcified fibroids.


    April 2022: Ethicon (J&J MedTech) introduced the ENSEAL X1 Straight Jaw Tissue Sealer, offering precise tissue sealing for myomectomy procedures.


    List of Myomectomy Key companies in the market:



    • Halt Medical, Inc. (U.K)

    • Boston Scientific Corporation (U.S.)

    • CooperSurgical Inc. (U.S.)

    • C. R. Bard, Inc. (U.S.)

    • F. Hoffmann-La Roche Ltd (Switzerland)

    • General Electric Company (U.S.)

    • KARL STORZ SE & Co. KG (Germany)

    • Richard Wolf Medical Instruments (U.S.)

    • Siemens (U.S.)

    • AbbVie Inc. (U.S.)

    • Bayer (Germany)

    • Eli Lilly and Company (U.S.)

    • Johnson & Johnson Services Inc. (U.S.)